{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:52:37Z","timestamp":1791571957362,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:p>Drug-induced aphthous ulcers have emerged as a significant concern in clinical practice; however, their epidemiological characteristics remain unclear. This study aimed to investigate the link between various medications and the occurrence of drug-induced aphthous ulcers using real-world data for a comprehensive analysis. We conducted an extensive analysis of adverse event reports from the U.S. Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS) from the third quarter of 2015 through the fourth quarter of 2024. By employing disproportionality analysis along with Bayesian confidence propagation neural network algorithms, we identified medications associated with aphthous ulcers, assessed their risk levels, and compared the time to onset for different drug categories. Additionally, univariate and multivariate logistic regression analyses were performed to explore independent risk factors (including demographic characteristics, clinical comorbidities, and drug exposure) for drug-induced aphthous ulcers. Our findings revealed that 426 medications were associated with the development of aphthous ulcers in the FAERS database. Disproportionality analysis identified 26 drugs with significant risk factors, with infliximab, methotrexate, everolimus, secukinumab, and palbociclib ranking among the top 5 drugs likely to induce aphthous ulcers. Logistic regression analyses confirmed that the top 5 drugs, along with 8 other medications, were independent risk factors for drug-induced aphthous ulcers. Age, sex, and multiple comorbidities were independent influencing factors. Additionally, the time-to-onset analysis indicated that most implicated drugs led to early failure. Identifying the risk factors associated with drug-induced aphthous ulcers underscores the need for a prevention-focused management strategy. Healthcare professionals must remain vigilant about the potential risks of specific medications in triggering aphthous ulcers and should proactively relay this information to patients. Increased awareness and continuous monitoring can significantly reduce the incidence of drug-related oral mucosal lesions.<\/jats:p>","DOI":"10.1097\/md.0000000000047844","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:03:03Z","timestamp":1773043383000},"page":"e47844","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Unveiling the risk: A comprehensive analysis of drug-induced aphthous ulcers using real-world data from FAERS"],"prefix":"10.1097","volume":"105","author":[{"given":"Xuefeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9763-7125","authenticated-orcid":false,"given":"Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12906-023-03886-0","article-title":"Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial.","volume":"23","author":"Umpreecha","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/lsm.23203","article-title":"Transoral low-level laser therapy via a cylindrical device to treat oral ulcers in a rodent model.","volume":"52","author":"Lee","year":"2020","journal-title":"Lasers Surg Med"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"1018567","DOI":"10.3389\/fimmu.2022.1018567","article-title":"A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4077\/CJP.2017.BAF462","article-title":"Stress as a cause of recurrent aphthous stomatitis and its correlation with salivary stress markers.","volume":"60","author":"Kunikullaya","year":"2017","journal-title":"Chin J Physiol"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.mehy.2011.04.006","article-title":"Occurrence of recurrent aphthous stomatitis only on lining mucosa and its relationship to smoking--a possible hypothesis.","volume":"77","author":"Subramanyam","year":"2011","journal-title":"Med Hypotheses"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/abd1806-4841.20186228","article-title":"Recurrent aphthous ulceration: an epidemiological study of etiological factors, treatment and differential diagnosis.","volume":"93","author":"Queiroz","year":"2018","journal-title":"An Bras Dermatol"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.3390\/ijms20205026","article-title":"Probiotics can cure oral aphthous-like ulcers in inflammatory bowel disease patients: a review of the literature and a working hypothesis.","volume":"20","author":"Cappello","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"411.e1","DOI":"10.1016\/j.genhosppsych.2011.01.010","article-title":"Aphthous ulcers associated with bupropion in a female adolescent: a case verified by rechallenge.","volume":"33","author":"Chiang","year":"2011","journal-title":"Gen Hosp Psychiatry"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.annder.2018.07.009","article-title":"Aphthous mouth ulcers as an initial manifestation of s\u00e9cukinumab-induced inflammatory bowel disease.","volume":"145","author":"Grimaux","year":"2018","journal-title":"Ann Dermatol Venereol"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0036933018785513","article-title":"Nicorandil-induced penile ulceration \u2013 surgical excision: case series and review of literature.","volume":"63","author":"Mokool","year":"2018","journal-title":"Scott Med J"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.adaj.2019.01.028","article-title":"Oral adverse reactions associated with etoricoxib, a common pain medication.","volume":"150","author":"Edel","year":"2019","journal-title":"J Am Dent Assoc"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"119010","DOI":"10.1016\/j.jep.2024.119010","article-title":"Ginkgo biloba extract safety: insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events.","volume":"337","author":"Yao","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1038\/s41598-024-67209-0","article-title":"Cardiac adverse events associated with lacosamide: a disproportionality analysis of the FAERS database.","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14740338.2022.2016696","article-title":"A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system.","volume":"21","author":"Shu","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jcpt.13024","article-title":"Time-to-onset analysis of amiodarone-associated thyroid dysfunction.","volume":"45","author":"Kinoshita","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/14712598.2021.1948529","article-title":"The impact of anti-TNF\u03b1 agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.","volume":"21","author":"Mazhar","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"R17-20261009","first-page":"1","article-title":"Post-marketing safety of adagrasib: a disproportionality analysis based on the FAERS database.","volume":"2","author":"Shi","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2025.2536343","article-title":"Safety assessment of esomeprazole: real-world adverse event signal mining and analysis based on FAERS database.","volume":"8","author":"Wang","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14740338.2025.2465867","article-title":"Assessment of adverse events of the novel antiepileptic drug lamotrigine: a real-world pharmacovigilance study based on FAERS.","volume":"24","author":"Tu","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2025.2527386","article-title":"Safety issues of Donepezil combined with Memantine in Alzheimer\u2019s disease population: real-world pharmacovigilance.","volume":"23","author":"Zeng","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5152\/tjg.2014.5415","article-title":"Drug-induced esophageal ulcers: case series and the review of the literature.","volume":"25","author":"Da\u011f","year":"2014","journal-title":"Turk J Gastroenterol"},{"key":"R22-20261009","first-page":"e161","article-title":"Hematinic deficiencies in patients with recurrent aphthous stomatitis: variations by gender and age.","volume":"23","author":"Bao","year":"2018","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1038\/sj.bdj.2015.100","article-title":"Impact of haematologic deficiencies on recurrent aphthous ulceration: a meta-analysis.","volume":"218","author":"Chen","year":"2015","journal-title":"Br Dent J"},{"key":"R24-20261009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.lpm.2016.01.005","article-title":"Aphthous ulcers and oral ulcerations.","volume":"45","author":"Vaillant","year":"2016","journal-title":"Presse Med"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jop.13499","article-title":"Cardiovascular diseases, risk factors, and ulcer relapse in older adults with aphthous stomatitis.","volume":"53","author":"Yao","year":"2024","journal-title":"J Oral Pathol Med"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/odi.13659","article-title":"Risk of autoimmune diseases in recurrent aphthous ulcer patients: a nationwide population study.","volume":"27","author":"Lee","year":"2021","journal-title":"Oral Dis"},{"issue":"Suppl 3","key":"R27-20261009","first-page":"36","article-title":"Biological agents in ulcerative colitis. When to prescribe.","volume":"34","author":"Barreiro-de Acosta","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"R28-20261009","first-page":"821","article-title":"Combination of adalimumab with traditional systemic antipsoriatic drugs \u2013 a report of 39 cases.","volume":"10","author":"Philipp","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/jdv.12662","article-title":"Bullous pemphigoid induced by m-TOR inhibitors in renal transplant recipients.","volume":"29","author":"Atzori","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/1871521409666170412123500","article-title":"Progress of CDK4\/6 inhibitor palbociclib in the treatment of cancer.","volume":"18","author":"Chen","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00005-011-0134-1","article-title":"Expression of Th1\/Th2\/Th3\/Th17-related genes in recurrent aphthous ulcers.","volume":"59","author":"Lewkowicz","year":"2011","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"e70351","DOI":"10.1002\/cam4.70351","article-title":"Clinical risk factors for high-dose methotrexate-induced oral mucositis following individualized dosing.","volume":"13","author":"Hu","year":"2024","journal-title":"Cancer Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:09:30Z","timestamp":1791569370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047844","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2025-03-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}